Highland Capital Management, LLC Ionis Pharmaceuticals Inc Transaction History

Highland Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$33.58 - $41.2 $91,068 - $111,734	-2,712 Reduced 6.73%	37,598 $1.34 Million
Q4 2022 Feb 07, 2023	BUY	$37.12 - $46.52 $53,341 - $66,849	1,437 Added 3.7%	40,310 $1.52 Million
Q3 2022 Nov 09, 2022	SELL	$36.54 - $48.66 $10,450 - $13,916	-286 Reduced 0.73%	38,873 $1.72 Million
Q2 2022 Jul 14, 2022	BUY	$31.71 - $43.0 $1.24 Million - $1.68 Million	39,159 New	39,159 $1.45 Million
Q4 2019 Feb 05, 2020	SELL	$53.85 - $65.27 $185,244 - $224,528	-3,440 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$59.06 - $72.15 $14,174 - $17,316	240 Added 7.5%	3,440 $206,000
Q1 2019 Apr 18, 2019	BUY	$52.92 - $81.17 $169,344 - $259,744	3,200 New	3,200 $260,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highland Capital Management, LLC with notifications on news.